Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

James V Caruso

CEO at Cellectar Biosciences, Inc. (CLRB)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-15.0%
vs. S&P 500-19.9%
Beat the market0%
Paper profit on buys−$12K
Total bought / sold$25K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 11SEC CLRBCellectar Biosciences, Inc. Buy 8,68020,318 held (+75%) $2.88 $25K -49.7%
  • Buy

    CEO James V Caruso bought $25K of CLRB at $2.88 — first open-market purchase in our records; raises the stake by 75%.